Probis expansion within dietary supplements continues

Probis expansion within dietary supplements continues

Probis partner Institut Rosell has signed agreements for the launch of dietary
supplements containing Probi's probiotic in Greece, the Czech Republic and
Slovakia. The launches will take place during fall. With this contract, sales of
dietary supplements containing Probi's probiotic will be underway in 14
countries.

”It is pleasing that the expansion in Europe is continuing now that we have
signed an agreement for three additional markets. The market's great interest
contributes to the expectations that the market area Dietary Supplements will,
within a two-year period, reach that of today's sales of the Functional Food
market area”, says Probi's Vice President, Per-Ola Forsberg.

The dietary supplements will be marketed by Smart Intermed in Greece and Rougier
in the Czech Republic and Slovakia. Furthermore, Probi is undergoing discussions
about launch of dietary supplements on other markets, and new agreements are
awaited to be signed in the near future. One of the main reasons behind the
continued great interest is the documented positive health benefits that Probi's
probiotics have.

The sales of dietary supplements containing Probi's probiotics are underway in
Australia, France, Greece, Canada, China, Scandinavia, Slovakia, the United
Kingdom, South Africa, the Czech Republic, Germany and the US. Several of these
agreements have been signed within the past twelve months.

Institut Rosell is one of the leading suppliers of probiotic dietary supplements
in the US and Europe. Probi and Institut Rosell are working the market parallel
to each other in order to reach the most effective market penetration of Probi's
bacteria Lp299v within dietary supplements. The total world market for probiotic
dietary supplements was appreciated at approximately 7 billion SEK and has shown
good growth during the past few years. 



For further information please contact:

Per-Ola Forsberg, Executive Vice President, tel: +46 (0)46 286 8926 or +46 (0)73
344 8384, 
e-mail: per-ola.forsberg@probi.se  
Rolf Bjerndell, Acting CEO, tel: +46 (0)46 286 8923 or +46 (0)70 515 3009, 
e-mail: rolf.bjerndell@probi.se   


About Probi 
Probi is a leading player in probiotic research and development. The company's
research is carried out using living micro- organisms with scientifically proven
health effects. The main research areas are: stomach and gastrointestinal
tracts, immune defense, risk factors for cardiovascular diseases, stress and
recovery. Probi's business concept is based on offering efficient and
well-documented probiotic product concepts with comprehensive patent protection,
which result in the possibility of considerably higher royalty levels than for
the sector as a whole. Probi's customers include leading companies in the
functional foods, dietary supplements and clinical nutrition marketing areas.
Since the middle of the 1990s, the Company has had continuous income from
commercialized products. Today, Probi cooperates with four licensees: Danone,
Skånemejerier, Institut Rosell and Health World. The global market for probiotic
products shows a favorable underlying growth. New insight into the advantages of
probiotics, an increasingly greater health interest and authorities' increasing
documentation demands and regulations are the primary trends that support Probi.
Probi's shares are listed on the Nordic Exchange. For further information, visit
www.probi.se.

About Institut Rosell-Lallemand
Institut Rosell is a French Canadian Company specializing in the selection,
development, production and marketing of probiotic formulations for human
nutrition and health. Expert in live microorganisms since 1934, Institut Rosell
undertakes ambitious research programs so as to better understand the
properties, modes of action and beneficial effects on health of these probiotic
formulations. Institut Rosell is part of the Lallemand group, a privately owned
company with head offices in Montreal, Canada, and Toulouse, France, and
production facilities in various countries around the world. For more
information, please visit www.institut-rosell.com or contact
human@lallemand.com.